Literature DB >> 20379727

[Is "going down to the gym" harmful for patients with inflammatory rheumatic disease?].

U Lange1.   

Abstract

The present article discusses the topic of "inflammatory rheumatic disease and commercial sports activities in fitness studios" with particular emphasis on joint protection.

Entities:  

Mesh：

Year:  2010        PMID： 20379727     DOI： 10.1007/s00393-010-0626-0

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN： 0340-1855            Impact factor:   1.372


  6 in total

1.  One-year outcomes of a randomized controlled trial of an educational-behavioural joint protection programme for people with rheumatoid arthritis.

Authors:  A Hammond; K Freeman
Journal:  Rheumatology (Oxford)       Date:  2001-09       Impact factor: 7.580

2.  Daily activities in women with rheumatoid arthritis. Aspects of patient education, assistive devices and methods for disability and impairment assessment.

Authors:  U Nordenskiöld
Journal:  Scand J Rehabil Med Suppl       Date:  1997

3.  Evaluation of assistive devices after a course in joint protection.

Authors:  U Nordenskiöld
Journal:  Int J Technol Assess Health Care       Date:  1994       Impact factor: 2.188

4.  The long-term outcomes from a randomized controlled trial of an educational-behavioural joint protection programme for people with rheumatoid arthritis.

Authors:  A Hammond; K Freeman
Journal:  Clin Rehabil       Date:  2004-08       Impact factor: 3.477

5.  A randomised controlled trial of occupational therapy for people with early rheumatoid arthritis.

Authors:  A Hammond; A Young; R Kidao
Journal:  Ann Rheum Dis       Date:  2004-01       Impact factor: 19.103

Review 6.  Effectiveness of nonpharmacological and nonsurgical interventions for patients with rheumatoid arthritis: an overview of systematic reviews.

Authors:  Anne Christie; Gro Jamtvedt; Kristin Thuve Dahm; Rikke H Moe; Espen A Haavardsholm; Kåre Birger Hagen
Journal:  Phys Ther       Date:  2007-09-25
  6 in total
  1 in total

Review 1.  [Sport and rheumatoid arthritis].

Authors:  D Proschek; S Rehart
Journal:  Z Rheumatol       Date:  2014-06       Impact factor: 1.372
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.